Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.
暂无分享,去创建一个
P. Zinzani | G. Martinelli | P. Tosi | S. Tura | G. Visani | P. Farabegoli | A. Zaccaria | M. Buzzi | A. Fortuna
[1] R. Fanin,et al. Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia , 1993, European journal of haematology.
[2] B. Barlogie,et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. , 1989, Blood.
[3] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[4] A. Fridland,et al. Differences in Metabolism and Cytotoxicity between 9-β-d-Arabinofuranosyladenine and 9-β-d-Arabinofuranosyl-2-fluoroadenine in Human Leukemic Lymphoblasts , 1980 .
[5] F. Schabel,et al. Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine , 1977 .
[6] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[7] H. Kantarjian,et al. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.